Immunology and Microbiology
Atopic Dermatitis
100%
Prevalence
81%
Sensitization
78%
Immunoglobulin E
60%
Contact Allergy
55%
Skin Allergy
54%
Atopy
51%
Asthma
46%
Eczema
45%
Allergen
41%
Anaphylaxis
36%
Food Allergy
32%
Patch Test
25%
Exercise Induced Anaphylaxis
24%
Clinical Immunology
20%
Mastocytosis
18%
Hand Eczema
18%
Nickel Hypersensitivity
16%
Contact Dermatitis
15%
Omalizumab
14%
Drug Hypersensitivity
12%
Allergic Rhinitis
11%
Epinephrine
11%
Dermatitis
11%
Cross-Reactivity
11%
Immunotherapy
11%
Biological Product
11%
Hen
10%
Wheat Allergy
10%
COVID-19
10%
Absorption
10%
Hypersensitive Response
8%
Vaccination Policy
8%
Contact Allergen
8%
Peanut Allergy
8%
Immunosuppressive Drug
7%
Histamine Release
7%
Mast Cell
7%
Birch
7%
Infancy
7%
Egg Allergy
6%
Comorbidity
6%
Passive Skin Anaphylaxis
6%
Tree
6%
Cow
5%
Basophil Activation
5%
Ingestion
5%
Ciclosporin
5%
Azathioprine
5%
Dupilumab
5%
Medicine and Dentistry
Atopic Dermatitis
80%
Patch Test
55%
Anaphylaxis
42%
Skin Allergy
39%
Symptom
35%
Contact Allergy
35%
Allergen
33%
Pediatrics
31%
Adolescent
31%
Disease
29%
Asthma
28%
Dermatology
28%
Clinical Immunology
28%
Diagnosis
25%
Sensitization
25%
Dermatitis
23%
Systemic Therapy
23%
Contact Dermatitis
22%
Urticaria
17%
Mastocytosis
17%
Prevalence
17%
Immunoglobulin E
16%
Atopy
15%
Drug Intolerance
14%
Clinician
14%
Eczema
13%
Nickel Hypersensitivity
13%
Epinephrine
13%
Mast Cell
12%
COVID-19
12%
Occupational Eczema
12%
Food Allergy
12%
Hand Eczema
11%
Cohort Analysis
11%
Biological Product
11%
Patient Population
10%
Eosinophilia
10%
Integrated Care Pathway
10%
Systemic Mastocytosis
10%
Exercise Induced Anaphylaxis
10%
Systematic Review
10%
Nonsteroid Antiinflammatory Agent
10%
Omalizumab
10%
Quality of Life
9%
Prick Test
9%
Chronic Urticaria
8%
Exanthem
8%
Dupilumab
8%
Drug Hypersensitivity
8%
Infancy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Anaphylaxis
83%
Atopic Dermatitis
53%
Skin Allergy
49%
Allergen
44%
Contact Allergy
43%
Immunoglobulin E
40%
Disease
27%
Prevalence
24%
Symptom
23%
Penicillin Derivative
22%
Food Allergy
21%
Omalizumab
21%
Penicillin Allergy
20%
Contact Dermatitis
20%
Immunotherapy
20%
Epinephrine
19%
Occupational Eczema
19%
Dermatitis
18%
Vaccination Policy
16%
Urticaria
16%
Coronavirinae
15%
Systemic Mastocytosis
15%
Retrospective Study
14%
Chronic Urticaria
14%
Systemic Treatment
13%
Prospective Study
13%
Drug Intolerance
12%
Epoxy Resin
11%
Histamine
11%
Pandemic
11%
Ethanol
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Acetylsalicylic Acid
10%
Macrogol
10%
Topical Corticosteroid
10%
Dupilumab
10%
Asthma
10%
Eczema
9%
Antihistaminic Agent
9%
Allergic Reaction
9%
Biological Product
9%
Adverse Event
9%
Excipient
8%
Gluten
7%
Erethism
7%
COVID-19 Vaccine
7%
Tixocortol Pivalate
7%
Mastocytosis
6%
Methylisothiazolinone
6%
Ciclosporin
6%
